Rakuten Kobo

Shopping Cart

Item(s) unavailable for purchase

Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.

itemsitem

- Unlimited access to eBooks
  
  Unlimited access to audiobooks
  
  No commitment, cancel anytime at kobo.com/account/subscriptions
  
  Get 1 credit every month for the audiobook of your choice
  
  No commitment, cancel anytime at kobo.com/account/subscriptions
  
  Unlimited access to eBooks
  
  Unlimited access to audiobooks
  
  No commitment, cancel anytime at kobo.com/account/subscriptions
  Audiobook
  by ,
  
  Available:
  
  . No commitment, cancel anytime at kobo.com/account/subscriptions.
  
  Pre-order
  1 audiobook monthly
  
  + FREE 30-day trial
  
  Special Offer
  
  Get 1 credit every month to exchange for an audiobook of your choice
  
  *No commitment, cancel anytime
  
  FREE

itemsitem

Unlimited access to eBooks

Unlimited access to audiobooks

No commitment, cancel anytime at kobo.com/account/subscriptions

Get 1 credit every month for the audiobook of your choice

No commitment, cancel anytime at kobo.com/account/subscriptions

Unlimited access to eBooks

Unlimited access to audiobooks

No commitment, cancel anytime at kobo.com/account/subscriptions
Audiobook
by ,

Available:
. No commitment, cancel anytime at kobo.com/account/subscriptions.

Pre-order
1 audiobook monthly

+ FREE 30-day trial

Special Offer

Get 1 credit every month to exchange for an audiobook of your choice

*No commitment, cancel anytime

FREE

Recommended For You

Skip side bar filters

Fundamentals of Market Access for Pharmaceuticals

by Eric Bouteiller, Annie Chicoye ...

”Because at the heart of the apparent conflict between public health concerns and capitalistic interests, market access for pharmaceuticals is largely driven by political considerations, the difference with usual consumer goods being that pharmaceuticals are saving lives or years of life in good health”.If pharmaceutical companies are to innovate, they must be incentivised with prices that reflect ... Read more

$40.99 USD

”Because at the heart of the apparent conflict between public health concerns and capitalistic interests, market access for pharmaceuticals is largely driven by political considerations, the difference with usual consumer goods being that pharmaceuticals are saving lives or years of life in good health”.If pharmaceutical companies are to innovate, they must be incentivised with prices that reflect
... Read more

Better Now

Six Big Ideas to Improve Health Care for All Canadians

by Dr. Danielle Martin ...

Longlisted for British Columbia's National Award for Canadian Non-Fiction 2018Dr. Danielle Martin sees the challenges in our health care system every day. As a family doctor and a hospital vice president, she observes how those deficiencies adversely affect patients. And as a health policy expert, she knows how to close those gaps. A passionate believer in the value of fairness that underpins the ... Read more

$15.99 USD

Longlisted for British Columbia's National Award for Canadian Non-Fiction 2018Dr. Danielle Martin sees the challenges in our health care system every day. As a family doctor and a hospital vice president, she observes how those deficiencies adversely affect patients. And as a health policy expert, she knows how to close those gaps. A passionate believer in the value of fairness that underpins the
... Read more
Side Effects

How Our Healthcare Lost Its Way – And How We Fix It

by David Haslam ...

In the shadow of the pandemic , how do we make a healthcare system that is affordable, effective and fair? With a single drug in the UK currently costing £ 340,000 per patient per year, or a gene therapy in the USA being costed at $1.2million, who should get such treatments, and how can we begin to afford them? Should we all be entitled to timely mental health therapy? How should we care for our ... Read more

$11.99 USD or Free with Kobo Plus

Also available as: Audiobook

In the shadow of the pandemic , how do we make a healthcare system that is affordable, effective and fair? With a single drug in the UK currently costing £ 340,000 per patient per year, or a gene therapy in the USA being costed at $1.2million, who should get such treatments, and how can we begin to afford them? Should we all be entitled to timely mental health therapy? How should we care for our
... Read more

Also available as: Audiobook
Treating Health Care

How the Canadian System Works and How It Could Work Better

by Raisa Deber ...

Series series UTP Insights
Canada has been among the world leaders in recognizing the multiple factors that impact health. Focusing on Canada’s health care system, Raisa B. Deber provides brief descriptions of some key facts and concepts necessary to understand health care policy in Canada and place it in an international context.An accessible guide, Treating Health Care unpacks key concepts to provide informed discussions ... Read more

$25.19 USD

Canada has been among the world leaders in recognizing the multiple factors that impact health. Focusing on Canada’s health care system, Raisa B. Deber provides brief descriptions of some key facts and concepts necessary to understand health care policy in Canada and place it in an international context.An accessible guide, Treating Health Care unpacks key concepts to provide informed discussions
... Read more
Doctors in Denial

Why Big Pharma and the Canadian medical profession are too close for comfort

by Joel Lexchin ...

Doctors in Denial examines the relationship between the Canadian medical profession and the pharmaceutical industry, and explains how doctors have become dependents of the drug companies instead of champions of patients' health. Big Pharma plays a role in every aspect of doctors' work. These giant, wealthy multinationals influence how medical students are trained and receive information, how ... Read more

$16.99 USD

Doctors in Denial examines the relationship between the Canadian medical profession and the pharmaceutical industry, and explains how doctors have become dependents of the drug companies instead of champions of patients' health. Big Pharma plays a role in every aspect of doctors' work. These giant, wealthy multinationals influence how medical students are trained and receive information, how
... Read more
Healthcare Management

by Kieran Walshe, Judith Smith ...

A comprehensive, research-based introduction to healthcare management, covering healthcare systems, services, organisations and management. ... Read more

$51.99 USD

A comprehensive, research-based introduction to healthcare management, covering healthcare systems, services, organisations and management.
... Read more
Human: Solving the global workforce crisis in healthcare

by Mark Britnell ...

By 2030, the world will be short of approximately 15 million health workers - a fifth of the workforce needed to keep healthcare systems going. Global healthcare leader and award-winning author, Dr Mark Britnell, uses his unique insights from advising governments, executives, and clinicians in more than 70 countries, to present solutions to this impending crisis. Human: Solving the Global ... Read more

$14.29 USD

By 2030, the world will be short of approximately 15 million health workers - a fifth of the workforce needed to keep healthcare systems going. Global healthcare leader and award-winning author, Dr Mark Britnell, uses his unique insights from advising governments, executives, and clinicians in more than 70 countries, to present solutions to this impending crisis. Human: Solving the Global
... Read more
From Breakthrough to Blockbuster

The Business of Biotechnology

by Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos ...

Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these ... Read more

$25.69 USD

Also available as: Audiobook

Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these
... Read more

Also available as: Audiobook
Pharmaceutical Market Access in Developed Markets

by Güvenç Koçkaya, Albert Wertheimer ...

Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization.It covers a group of activities intended to provide access to the appropriate medicine for the ... Read more

$10.99 USD or Free with Kobo Plus

Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization.It covers a group of activities intended to provide access to the appropriate medicine for the
... Read more
Private Profits versus Public Policy

The Pharmaceutical Industry and the Canadian State

by Joel Lexchin ...

The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren’t the interests of the public supposed to supersede the pursuit of private profit?In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy ... Read more

$31.99 USD

The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren’t the interests of the public supposed to supersede the pursuit of private profit?In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy
... Read more
Affordable Excellence

The Singapore Healthcare Story

by William A. Haseltine ...

A Brookings Institution Press and the National University of Singapore Press publicationThis is the story of the Singapore healthcare system: how it works, how it is financed, its history, where it is going, and what lessons it may hold for national health systems around the world. Singapore ranks sixth in the world in healthcare outcomes, yet spends proportionally less on healthcare than any ... Read more

$20.59 USD

A Brookings Institution Press and the National University of Singapore Press publicationThis is the story of the Singapore healthcare system: how it works, how it is financed, its history, where it is going, and what lessons it may hold for national health systems around the world. Singapore ranks sixth in the world in healthcare outcomes, yet spends proportionally less on healthcare than any
... Read more
The Health Care Handbook

A Clear and Concise Guide to the United States Health Care System

by Elisabeth T. Askin, Nathan Moore ...

Described in the New York Times as “an astonishingly clear ‘user’s manual’ that explains our health care system and the policies that will change it,” The Health Care Handbook, by Drs. Elisabeth Askin and Nathan Moore, offers a practical, neutral, and readable overview of the U.S. health care system in a compact, convenient format. The fully revised third edition provides concise coverage on ... Read more

$35.99 USD

Described in the New York Times as “an astonishingly clear ‘user’s manual’ that explains our health care system and the policies that will change it,” The Health Care Handbook, by Drs. Elisabeth Askin and Nathan Moore, offers a practical, neutral, and readable overview of the U.S. health care system in a compact, convenient format. The fully revised third edition provides concise coverage on
... Read more

Rakuten Kobo

eReaders

Apps

Accessories

What is Kobo Super Points?

Reward Yourself

Shopping Cart

You're getting the VIP treatment!

Your Shopping Cart is empty

Available:

1 audiobook monthly

+ FREE 30-day trial

Available:

1 audiobook monthly

+ FREE 30-day trial

Recommended For You

“eric bouteiller”

Fundamentals of Market Access for Pharmaceuticals

People who read this also enjoyed

Better Now

Side Effects

Treating Health Care

Doctors in Denial

Healthcare Management

Human: Solving the global workforce crisis in healthcare

From Breakthrough to Blockbuster

Pharmaceutical Market Access in Developed Markets

Private Profits versus Public Policy

Affordable Excellence

The Health Care Handbook

eReaders

Apps

Accessories

Shopping Cart

You're getting the VIP treatment!

Your Shopping Cart is empty

Available:

1 audiobook monthly

+ FREE 30-day trial

Available:

1 audiobook monthly

+ FREE 30-day trial

Recommended For You

“eric bouteiller”

Show:

People who read this also enjoyed